Notre Dame’s Richard Taylor, Interim Director of the Warren Family Research Center for Drug Discovery and Development and Professor of Chemistry & Biochemistry has been selected to participate in a National Institutes of Health training program, “Neurotherapeutics Discovery and Development for Academic Scientists.” In addition to fundamental principles of discovery, development, and IND enabling studies, the course will also address the unique challenges inherent in developing treatments for nervous system disorders.
Thursday (Feb. 4) marks World Cancer Day. World Cancer Day was established by the Paris Charter adopted at the World Summit Against Cancer for the New Millennium in Paris on Feb. 4, 2000. The goals of the charter are the promotion of research to cure as well as prevent the disease, upgrades to the provided services to the patients, the sensitization of the common opinion and the mobilization of the global community against cancer.
Five University of Notre Dame faculty members — Bertrand Hochwald and J. Nicholas Laneman from the College of Engineering, Timothy Beers and Prashant Kamat from the College of Science, and Luis Gómez-Mejia from the Mendoza College of Business — have been named to the 2015 Thomson Reuters’ Highly Cited Researchers list. The list identifies the top 1 percent of the almost 9 million scholars and scientists who publish their academic findings every year, accounting for more than 2 million journal papers.
Zachary Schultz, Associate Professor of Chemistry and Biochemistry, has accepted an invitation to join the Features Panel of the journal Analytical Chemistry. This appointment is for a three-year term beginning in 2016.
Travis Marshall-Roth (’15) has been selected as the winner of the 2016 American Chemical Society Division of Inorganic Chemistry Award for Undergraduate Research for students at research universities. Marshall-Roth and his research advisor Seth Brown, professor of chemistry and biochemistry, were recognized for their work elucidating the reaction mechanism for non-classical oxygen atom transfers and developing new catalyst designs with multiple redox-active ligands.
The Notre Dame Initiative for Global Development (NDIGD) and Professor Marya Lieberman have won a USAID Development Innovation Ventures award to improve global health.
The Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame has established a research collaboration with Retrophin, Inc. and the Grace Wilsey Foundation to focus on developing treatment for NGLY1 deficiency. …
Amanda Hummon, the Husking Foundation, Inc. Associate Professor of Chemistry and Biochemistry, has received a 2016 Rising Star Award from the American Chemical Society’s Women Chemists Committee. Hummon will accept the award at the national American Chemical Society (ACS) meeting in San Diego in March.
Notre Dame researchers led by Ken Henderson have achieved a critical step in the search for rapid molecular-based computing. The group demonstrated the ability to move an electron within a neutral molecule, providing the binary switch necessary for computing. A key advance is that the molecule does not require the presence of a second molecule to generate the electron, which creates bias in the system.
University of Notre Dame faculty members — Timothy Beers and Prashant Kamat from the College of Science and Bertrand Hochwald and J. Nicholas Laneman from the College of Engineering and — have been named to the Thomson Reuters’ list of Highly Cited Researchers for 2015. Hochwald, Beers, and Kamat were named in the 2014 list. All four faculty members have also appeared on previous years’ lists.
The University of Notre Dame has received $133.7 million in research funding for fiscal year 2015. This is an all-time record for the University and $20 million more than last year.
Professor Marya Lieberman has been awarded a grant from the US Agency for International Development (USAID) to monitor the quality of pharmaceuticals across western Kenya through the use of innovative diagnostic test cards developed in her laboratory. These inexpensive, point-of-need devices have been shown to detect falsified antibiotics, TB medications, and anti-malarial drugs.
Aaron Timperman, Ph.D., has joined the University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative as its new Associate Director-Research. “Aaron is an analytical scientist and bioengineer with extensive experience in many of the areas at the core of AD&T’s R&D portfolio,” Paul Bohn, Schmitt Professor of Chemical and Biomolecular Engineer and Director of AD&T, said. Timperman will have a concurrent appointment in the Department of Chemistry and Biochemistry.
Patricia Clark, the Rev. John Cardinal O'Hara C.S.C Professor of Biochemistry, has been elected to the executive council of the Protein Society. She will serve a three-year term (2015-18), during which she will work with the other councilors to organize and conduct the society’s business and help plan conferences and other activities for the organization’s membership.
Twenty doctoral students from Europe, Latin America, and the United States are participating in the Santander International Summer School on molecular catalysts from July 14-24 at the Heidelberg Center for Latin America in Santiago, Chile. Organized by the University of Notre Dame, University of Heidelberg in Germany, and the Pontifical Catholic University of Chile (PUC) in Santiago, the summer school will highlight the fundamentals and current developments in the field of molecular catalysts, with an emphasis on catalysts as synthetic tools.
Immediate change is needed at all levels to improve the quality of science, technology, engineering and mathematics (STEM) education in research universities, according to a paper on undergraduate STEM learning and teaching co-authored by Zachary Schultz, associate professor of chemistry and biochemistry at the University of Notre Dame, that appears in a special July issue of the journal Nature.
A new paper by a team of researchers that includes Haifeng Gao, an assistant professor of chemistry and biochemistry at the University of Notre Dame, presents, for the first time, a one-pot, one-batch synthesis of hyperbranched polymers with tunablemolecular weights, uniform size and high degree of branching using an efficient click polymerization technique.
With cancer affecting millions of lives each year, Notre Dame scientists are working to develop personalized cancer vaccine therapies with the help of computational modeling. The recent acquisition of a General Purpose Graphics Processing Unit (GPGPU) computer cluster has significantly accelerated output for Notre Dame researchers. Led by Brian Baker, associate dean for research and graduate studies in the College of Science and professor of chemistry and biochemistry, an interdisciplinary team of biophysicists, biochemists and immunologists are using the GPGPU cluster to develop new immunotherapeutics. The cluster is maintained and housed by the Center for Research Computing at Union Station Technology Center, downtown South Bend.
The first Joint Summer School in Computational Chemistry was held at Heidelberg University in Germany July 6-11. Organized by the Department of Chemistry and Biochemistry at the University of Notre Dame and the Institute of Inorganic Chemistry and Interdisciplinary Center for Scientific Computing at Heidelberg University, the six day program provided the opportunity for students who primarily work on experimental research to combine their studies with theory-based approaches, in particular with electronic-structure-based computational chemistry.